Your browser doesn't support javascript.
loading
Formulation and optimization of a single-layer coat for targeting budesonide pellets to the descending Colon.
Soltani, Fatemeh; Kamali, Hossein; Akhgari, Abbas; Afrasiabi Garekani, Hadi; Nokhodchi, Ali; Sadeghi, Fatemeh.
Afiliação
  • Soltani F; Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Kamali H; Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Akhgari A; Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Afrasiabi Garekani H; Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Nokhodchi A; Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Sadeghi F; Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Pharm Dev Technol ; 29(3): 212-220, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38392961
ABSTRACT
The current budesonide formulations are inadequate for addressing left-sided colitis, and patients might hesitate to use an enema for a prolonged time. This study focuses on developing a single-layer coating for budesonide pellets targeting the descending colon. Pellets containing budesonide (1.5%w/w), PVP K30 (5%w/w), lactose monohydrate (25%w/w) and Avicel pH 102 (68.5%w/w) were prepared using extrusion spheronization technique. Coating formulations were designed using response surface methodology with pH and time-dependent Eudragits. Dissolution tests were conducted at different pH levels (1.2, 6.5, 6.8, and 7.2). Optimal coating formulation, considering coating level and the Eudragit (S + L) ratio to the total coating weight, was determined. Budesonide pellets were coated with the optimized composition and subjected to continuous dissolution testing simulating the gastrointestinal tract. The coating, with 48% S, 12% L, and 40% RS at a 10% coating level, demonstrated superior budesonide delivery to the descending colon. Coated pellets had a spherical shape with a uniform 30 µm thickness coating, exhibiting pH and time-dependent release. Notably, zero-order release kinetics was observed for the last 9 h in colonic conditions. The study suggests that an optimized single-layer coating, incorporating pH and time-dependent polymers, holds promise for consistently delivering budesonide to the descending colon.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Polimetacrílicos / Sistemas de Liberação de Medicamentos / Budesonida Limite: Humans Idioma: En Revista: Pharm Dev Technol Assunto da revista: FARMACIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Polimetacrílicos / Sistemas de Liberação de Medicamentos / Budesonida Limite: Humans Idioma: En Revista: Pharm Dev Technol Assunto da revista: FARMACIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã